Cargando…
Impaired phosphate transport in SLC34A2 variants in patients with pulmonary alveolar microlithiasis
BACKGROUND: Variants in SLC34A2 encoding the sodium-dependent phosphate transport protein 2b (NaPi-IIb) cause the rare lung disease pulmonary alveolar microlithiasis (PAM). PAM is characterised by the deposition of calcium-phosphate concretions in the alveoli usually progressing over time. No effect...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019944/ https://www.ncbi.nlm.nih.gov/pubmed/35443721 http://dx.doi.org/10.1186/s40246-022-00387-y |
_version_ | 1784689412761714688 |
---|---|
author | Jönsson, Åsa Lina M. Hernando, Nati Knöpfel, Thomas Mogensen, Susie Bendstrup, Elisabeth Hilberg, Ole Christensen, Jane Hvarregaard Simonsen, Ulf Wagner, Carsten A. |
author_facet | Jönsson, Åsa Lina M. Hernando, Nati Knöpfel, Thomas Mogensen, Susie Bendstrup, Elisabeth Hilberg, Ole Christensen, Jane Hvarregaard Simonsen, Ulf Wagner, Carsten A. |
author_sort | Jönsson, Åsa Lina M. |
collection | PubMed |
description | BACKGROUND: Variants in SLC34A2 encoding the sodium-dependent phosphate transport protein 2b (NaPi-IIb) cause the rare lung disease pulmonary alveolar microlithiasis (PAM). PAM is characterised by the deposition of calcium-phosphate concretions in the alveoli usually progressing over time. No effective treatment is available. So far, 30 allelic variants in patients have been reported but only a few have been functionally characterised. This study aimed to determine the impact of selected SLC34A2 variants on transporter expression and phosphate uptake in cellular studies. METHODS: Two nonsense variants (c.910A > T and c.1456C > T), one frameshift (c.1328delT), and one in-frame deletion (c.1402_1404delACC) previously reported in patients with PAM were selected for investigation. Wild-type and mutant c-Myc-tagged human NaPi-IIb constructs were expressed in Xenopus laevis oocytes. The transport function was investigated with a (32)Pi uptake assay. NaPi-IIb protein expression and localisation were determined with immunoblotting and immunohistochemistry, respectively. RESULTS: Oocytes injected with the wild-type human NaPi-IIb construct had significant (32)Pi transport compared to water-injected oocytes. In addition, the protein had a molecular weight as expected for the glycosylated form, and it was readily detectable in the oocyte membrane. Although the protein from the Thr468del construct was synthesised and expressed in the oocyte membrane, phosphate transport was similar to non-injected control oocytes. All other mutants were non-functional and not expressed in the membrane, consistent with the expected impact of the truncations caused by premature stop codons. CONCLUSIONS: Of four analysed SLC34A2 variants, only the Thr468del showed similar protein expression as the wild-type cotransporter in the oocyte membrane. All mutant transporters were non-functional, supporting that dysfunction of NaPi-IIb underlies the pathology of PAM. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40246-022-00387-y. |
format | Online Article Text |
id | pubmed-9019944 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-90199442022-04-21 Impaired phosphate transport in SLC34A2 variants in patients with pulmonary alveolar microlithiasis Jönsson, Åsa Lina M. Hernando, Nati Knöpfel, Thomas Mogensen, Susie Bendstrup, Elisabeth Hilberg, Ole Christensen, Jane Hvarregaard Simonsen, Ulf Wagner, Carsten A. Hum Genomics Research BACKGROUND: Variants in SLC34A2 encoding the sodium-dependent phosphate transport protein 2b (NaPi-IIb) cause the rare lung disease pulmonary alveolar microlithiasis (PAM). PAM is characterised by the deposition of calcium-phosphate concretions in the alveoli usually progressing over time. No effective treatment is available. So far, 30 allelic variants in patients have been reported but only a few have been functionally characterised. This study aimed to determine the impact of selected SLC34A2 variants on transporter expression and phosphate uptake in cellular studies. METHODS: Two nonsense variants (c.910A > T and c.1456C > T), one frameshift (c.1328delT), and one in-frame deletion (c.1402_1404delACC) previously reported in patients with PAM were selected for investigation. Wild-type and mutant c-Myc-tagged human NaPi-IIb constructs were expressed in Xenopus laevis oocytes. The transport function was investigated with a (32)Pi uptake assay. NaPi-IIb protein expression and localisation were determined with immunoblotting and immunohistochemistry, respectively. RESULTS: Oocytes injected with the wild-type human NaPi-IIb construct had significant (32)Pi transport compared to water-injected oocytes. In addition, the protein had a molecular weight as expected for the glycosylated form, and it was readily detectable in the oocyte membrane. Although the protein from the Thr468del construct was synthesised and expressed in the oocyte membrane, phosphate transport was similar to non-injected control oocytes. All other mutants were non-functional and not expressed in the membrane, consistent with the expected impact of the truncations caused by premature stop codons. CONCLUSIONS: Of four analysed SLC34A2 variants, only the Thr468del showed similar protein expression as the wild-type cotransporter in the oocyte membrane. All mutant transporters were non-functional, supporting that dysfunction of NaPi-IIb underlies the pathology of PAM. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40246-022-00387-y. BioMed Central 2022-04-20 /pmc/articles/PMC9019944/ /pubmed/35443721 http://dx.doi.org/10.1186/s40246-022-00387-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Jönsson, Åsa Lina M. Hernando, Nati Knöpfel, Thomas Mogensen, Susie Bendstrup, Elisabeth Hilberg, Ole Christensen, Jane Hvarregaard Simonsen, Ulf Wagner, Carsten A. Impaired phosphate transport in SLC34A2 variants in patients with pulmonary alveolar microlithiasis |
title | Impaired phosphate transport in SLC34A2 variants in patients with pulmonary alveolar microlithiasis |
title_full | Impaired phosphate transport in SLC34A2 variants in patients with pulmonary alveolar microlithiasis |
title_fullStr | Impaired phosphate transport in SLC34A2 variants in patients with pulmonary alveolar microlithiasis |
title_full_unstemmed | Impaired phosphate transport in SLC34A2 variants in patients with pulmonary alveolar microlithiasis |
title_short | Impaired phosphate transport in SLC34A2 variants in patients with pulmonary alveolar microlithiasis |
title_sort | impaired phosphate transport in slc34a2 variants in patients with pulmonary alveolar microlithiasis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019944/ https://www.ncbi.nlm.nih.gov/pubmed/35443721 http://dx.doi.org/10.1186/s40246-022-00387-y |
work_keys_str_mv | AT jonssonasalinam impairedphosphatetransportinslc34a2variantsinpatientswithpulmonaryalveolarmicrolithiasis AT hernandonati impairedphosphatetransportinslc34a2variantsinpatientswithpulmonaryalveolarmicrolithiasis AT knopfelthomas impairedphosphatetransportinslc34a2variantsinpatientswithpulmonaryalveolarmicrolithiasis AT mogensensusie impairedphosphatetransportinslc34a2variantsinpatientswithpulmonaryalveolarmicrolithiasis AT bendstrupelisabeth impairedphosphatetransportinslc34a2variantsinpatientswithpulmonaryalveolarmicrolithiasis AT hilbergole impairedphosphatetransportinslc34a2variantsinpatientswithpulmonaryalveolarmicrolithiasis AT christensenjanehvarregaard impairedphosphatetransportinslc34a2variantsinpatientswithpulmonaryalveolarmicrolithiasis AT simonsenulf impairedphosphatetransportinslc34a2variantsinpatientswithpulmonaryalveolarmicrolithiasis AT wagnercarstena impairedphosphatetransportinslc34a2variantsinpatientswithpulmonaryalveolarmicrolithiasis |